Table 3.
A list of the approved Indian biosimilars which accounts for only 3% of global share.
| Product | Company Name | Active Drug Molecule | Therapeutic Use in |
|---|---|---|---|
| Glaritus | Wockhardt | Insulin Glargine | Diabetes |
| Grafeel | Dr. Reddy’s Laboratories | Filgrastin | Neutropenia |
| Pegfilgrastism | Lupin | Pegfilgrastin | Cancer, Neutropenia |
| Epofer | Emcure | Epoetin alpha | Anemia |
| Zyrop | Cadila Healthcare | Erythropeotin | Chronic kidney failure |
| Krabeva | Biocon | Bevacizumab | Colorectal cancer |
| Bevacirel | Reliance Life Sciences | ||
| Cizumab | Hetero | ||
| Erbitux | Cetuximab | Colorectal cancer | |
| Acellbia | Biocad | Rituximab | NonHodgkin Lymphoma |
| Maball | Hetero Group | ||
| maTabs | Intas Pharmaceuticals | ||
| Adafrar | Torrent Pharmaceuticals | Adalimumab | Rheumatoid Athritis, Crohn’s disease |
| CaNMab | Biocon | Transtuzumab | Breast cancer |
| Intacept | Intas Pharmaceuticals | Entanercept | Rheumatoid Athritis |
| Relibeta | Reliance Life Sciences | Interferon Beta 1a | Multiple sclerosis |
| Razumab | Intas Pharmaceuticals | Ranibizumab | Degenerative myopia |
| AbcixiRel | Reliance Life Sciences | Abciximab | Angina, Cardiac ischemia |
| Basalog | Biocon | insulin glargine | Diabetes |
| Biovac-B | Wockhardt | hepatitis B vaccine | Hepatitis B |
| FostiRel | Reliance Life Sciences | follitropin beta | Female infertility |
| Mirel | Reliance Life Sciences | reteplase | Myocardial Infraction |
| Zavinex | Cadila Health Care | Interferon alfa-2b | Chronic hepatitis B and C |
| Choriorel | Reliance Life Sciences | chorionic gonadotrophin hormone r-hCG | Female infertility |